--- title: "KZIA.US (KZIA.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/KZIA.US/news.md" symbol: "KZIA.US" name: "KZIA.US" parent: "https://longbridge.com/en/quote/KZIA.US.md" datetime: "2026-06-13T16:30:54.243Z" locales: - [en](https://longbridge.com/en/quote/KZIA.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/KZIA.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/KZIA.US/news.md) --- # KZIA.US (KZIA.US) — Related News ### [Analyst Raises Kazia’s Price Target to $30 and Reiterates Buy on Strengthened Confidence in PI3K/AKT/mTOR Strategy](https://longbridge.com/en/news/288773686.md) *2026-06-04T18:45:21.000Z* > Maxim Group analyst Naz Rahman reiterated a Buy rating on Kazia Therapeutics (KZIA), raising the 12-month price target t ### [Kazia Therapeutics Appoints James Levine as Chief Financial Officer | KZIA Stock News](https://longbridge.com/en/news/288415510.md) *2026-06-02T03:30:50.000Z* > Kazia Therapeutics Appoints James Levine as Chief Financial Officer | KZIA Stock News ### [Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer | KZIA Stock News](https://longbridge.com/en/news/287627288.md) *2026-05-26T03:30:28.000Z* > Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer | KZIA Stock News ### [Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform | KZIA Stock News](https://longbridge.com/en/news/282839865.md) *2026-04-15T04:00:44.000Z* > Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Le ### [Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform | KZIA Stock News](https://longbridge.com/en/news/282591392.md) *2026-04-13T13:10:49.000Z* > Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform | KZIA Stock